• / Free eNewsletters & Magazine
  • / My Account
Home>Stocks>Theravance

Related Topics

  1. USAA Large Value
  2. USAA Large Growth
  3. USAA Large Blend
  4. Fidelity Large Value
  5. Fidelity Small Value
  6. Fidelity Large Growth

Popular Topics

  1. Eagle Bulk Shipping
  2. iShares S&P Global Timber & Forestry Idx
  3. Hong Kong
  4. Labor Market
  5. Emerging Markets

Theravance

Theravance THRX

Last Price$36.96Day Change (%)-6.63%
Open Price$39.47Day Change ($)-2.62
Day Range36.92–39.4752-Week Range17.06–42.41

As of Mon 05/20/2013 02:52 PM EDT | USD

  1. All
  2. Morningstar Articles
  3. 3rd Party
  1. Theravance and Elan Enter Into a $1.0 Billion Royalty Participation Agreement

    Theravance and Elan Enter Into a $1.0 Billion Royalty Participation Agreement

  2. Elan, Theravance Enter Into $1.0 Billion Royalty Participation Pact

    Elan, Theravance Enter Into $1.0 Billion Royalty Participation Pact

  3. The Benefits of Diversifying the Funding of a Gold Position

    Theravance THRX reported second-quarter earnings that matched our expectations, and we are keeping our fair value estimate at $29 per share. The company continues to make progress in each of its programs, namely the addition of a second Phase IIb compound in the Beyond Advair trials and completion ...

  4. Elan Sets Out Deal Plans

    Elan Sets Out Deal Plans

  5. Elan Provides Additional Commentary on Elan/Theravance Royalty Participation Agreement

    Elan Provides Additional Commentary on Elan/ Theravance Royalty Participation Agreement

  6. Elan Announces Proposed Offering of US$800.0 Million in Aggregate Principal Amount of Senior Notes Due 2021

    Elan Announces Proposed Offering of US$800.0 Million in Aggregate Principal Amount of Senior Notes Due 2021

  7. Elan Announces Transactions: Decisively Transforming the Company

    Elan Announces Transactions: Decisively Transforming the Company

  8. U.S. Stock Futures Pare Losses After Retail Sales Data

    U.S. Stock Futures Pare Losses After Retail Sales Data

Our Products
Tools
Resources
Services
Upcoming Events
Conferences
Webinars

©2012 Morningstar Advisor. All right reserved.